ScoreWhy is Ningbo Menovo Pharmaceutical Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 2.46% and Operating profit at -10.76% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 7.75% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 2.46% and Operating profit at -10.76% over the last 5 years
3
Positive results in Mar 25
- NET SALES(HY) At CNY 687.3 MM has Grown at 27.22%
- NET PROFIT(HY) Higher at CNY 20.03 MM
- PRE-TAX PROFIT(Q) At CNY 27.42 MM has Grown at 85.87%
4
With ROE of 4.79%, it has a attractive valuation with a 2.06 Price to Book Value
- Over the past year, while the stock has generated a return of 43.99%, its profits have risen by 599.1% ; the PEG ratio of the company is 0.1
- At the current price, the company has a high dividend yield of 0.2
5
Market Beating Performance
- The stock has generated a return of 43.99% in the last 1 year, much higher than market (China Shanghai Composite) returns of 14.77%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Ningbo Menovo Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Ningbo Menovo Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Ningbo Menovo Pharmaceutical Co., Ltd.
43.99%
1.49
49.45%
China Shanghai Composite
14.77%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.46%
EBIT Growth (5y)
-10.76%
EBIT to Interest (avg)
4.39
Debt to EBITDA (avg)
3.33
Net Debt to Equity (avg)
0.40
Sales to Capital Employed (avg)
0.34
Tax Ratio
13.04%
Dividend Payout Ratio
15.88%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.73%
ROE (avg)
7.75%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
43
Industry P/E
Price to Book Value
2.06
EV to EBIT
46.51
EV to EBITDA
20.70
EV to Capital Employed
1.76
EV to Sales
3.90
PEG Ratio
0.07
Dividend Yield
0.23%
ROCE (Latest)
3.77%
ROE (Latest)
4.79%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
NET SALES(HY)
At CNY 687.3 MM has Grown at 27.22%
NET PROFIT(HY)
Higher at CNY 20.03 MM
PRE-TAX PROFIT(Q)
At CNY 27.42 MM has Grown at 85.87%
-12What is not working for the Company
INTEREST(HY)
At CNY 37.93 MM has Grown at 147.26%
NET SALES(Q)
At CNY 271.99 MM has Fallen at -19.56%
OPERATING PROFIT(Q)
Lowest at CNY 27.06 MM
Here's what is working for Ningbo Menovo Pharmaceutical Co., Ltd.
Net Profit
At CNY 20.03 MM has Grown at 134.28%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Net Profit
Higher at CNY 20.03 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CNY MM)
Pre-Tax Profit
At CNY 27.42 MM has Grown at 85.87%
over average net sales of the previous four periods of CNY 14.75 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Here's what is not working for Ningbo Menovo Pharmaceutical Co., Ltd.
Interest
At CNY 37.93 MM has Grown at 147.26%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
At CNY 271.99 MM has Fallen at -19.56%
over average net sales of the previous four periods of CNY 338.12 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY 27.06 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
